Next-gen Alzheimer's drugs extend independent living by months
In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...
Quincy man becomes first Alzheimer’s patient to try nasal spray drug: ‘I’m hoping like heck’
Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...
Can a Drug Prevent Alzheimer’s Disease Decades Before It Happens?
Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.
How greed and profit fueled one failed Alzheimer drug
Matt Price drove his 73-year-old father Stephen from their New Jersey home to a medical strip mall on the Jersey Shore, for ...
To Protect Against Alzheimer’s, Researchers Look to Weight Loss Drugs
One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the ...
Rolling Out3d
Alzheimer’s drug prevents brain cell damage in medical
Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...
News Medical on MSN1d
Alzheimer’s Discovery Opens the Way to Complimentary Drug Treatments
A complementary drug to combat Alzheimer’s disease could target a specific part of the nerve cell protein tau.
Meet the 24-year-old helping Lilly test a preventive Alzheimer’s drug
Children who inherit genetic mutations from parents with early-onset Alzheimer’s typically show signs of dementia at the same ...
A New Test Could Help Identify Alzheimer's Risk Up To 10 Years Earlier
The test could help identify one key Alzheimer's biomarker, tau protein, before it shows up in brain. Here's what experts say ...
NKGen Biotech Announces Publication of Phase 1 Troculeucel Clinical Trial Results for the Treatment of Alzheimer’s Disease
The results from Phase 1 of the Troculeucel Clinical Trial demonstrated stable/improved outcomes in 90% of subjects, with no drug-related adverse ...
Brain rhythms can predict seizure risk in Alzheimer's disease patients, study finds
A UCLA Health research team has identified changes in brain rhythms that indicate seizure activity in Alzheimer's patients.
Stopping Alzheimer’s Before It Starts: Landmark Trial Enrolls First Participants
WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms arise Researchers at Washington University School of Medicine in St. Louis have ...